DataKnowledgeCloudtrainingcoordination

L1000 LINCS DCIC REP.B002 HA1E 24H K17 amiodarone 0.03uM.tsv.gz (File)

Taxon:

Homo sapiens

Taxon (Entity type)

Subject:

HA1E

Subject (Entity type)

Project:

LINCS-2021

Project (Entity type)

File Format:

TSV

File Format (Entity type)

Dcc Asset:

datapackage.zip

Processed File (Entity type)

Dcc:

LINCS

DCC (Entity type)

Data Type:

gene expression profile

Data Type (Entity type)

Compression Format:

GZIP format

File Format (Entity type)

Biosample:

L1000 LINCS DCIC 2021 REP.B002 HA1E 24H K17 amiodarone 0.03uM

Biosample (Entity type)

Assay Type:

landmark transcript profiling assay

Assay Type (Entity type)

Anatomy:

kidney

Anatomy (Entity type)

Uncompressed Size In Bytes:362 KB

Size In Bytes:167 KB

Sha256:5d8fc2a4057688609f8ab13815d2000ac061e089aab9434d7211f19c901fe29b

Persistent Id:drs://drs.lincs-dcic.org/5621d34c2f5b3ddd413cc967c9db1835

Mime Type:application/gzip

Md5:5621d34c2f5b3ddd413cc967c9db1835

Filename:L1000_LINCS_DCIC_REP.B002_HA1E_24H_K17_amiodarone_0.03uM.tsv.gz

Creation Time:2021-01-21T00:00:00

Access Url:

drs://drs.lincs-dcic.org/5621d34c2f5b3ddd413cc967c9db1835

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 REP.B002 HA1E 24H K17 amiodarone 0.03uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 REP.B002 HA1E 24H K17 amiodarone 0.03uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.